A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729

StatusRecruiting
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Start date changed from estimate of Sep 2026 to Sep 28, 2026
    • Site details revised
  2. Re-verified, no change to tracked fields
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This study assesses the safety, tolerability, and pharmacokinetics (PK) of the tablet formulation of TRTL-729 in healthy adults.
Trial Details
NCT Number NCT07811063
Lead Sponsor Tortugas Neuroscience, Inc.
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov